SCHEMBL3585318

SCHEMBL3585318

CCOC(=O)c1cc(CNC(C)C)cc(C(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOTUM Q6P988 1/20 0.45
▸ NPSR1 Q6W5P4 2/20 0.43
▸ ATF1 P18846 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ USP2 O75604 2/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ ADRA2C P18825 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ SLC6A2 P23975 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ HRH1 P35367 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585844 0.82 MRGPRX4 (0.45) NPSR1
SCHEMBL1996172 0.80 CA12 (0.56) NOTUMATF1NFKB1CYP3A4CYP1A2
SCHEMBL9967387 0.80 NOTUM (0.47) NOTUMATF1NFKB1CYP3A4CYP1A2
SCHEMBL16729317 0.80 NOTUM (0.47) NOTUMATF1NFKB1CYP3A4CYP1A2
SCHEMBL14569541 0.77 IDO1 (0.47) ADRA2CHTR2AHTR2CSLC6A4ADRA1A
SCHEMBL13168235 0.75 CA12 (0.69) NOTUMATF1NFKB1CYP3A4PRKCA
SCHEMBL671602 0.75 NOTUM (0.71) NOTUMATF1NFKB1CYP3A4CYP1A2
SCHEMBL4829568 0.75 CA12 (0.50) NOTUMATF1NFKB1CA12CA1
SCHEMBL18252826 0.74 ALDH1A1 (0.41) HTR1AADRA2CHTR2AHTR2CSLC6A4
SCHEMBL18252800 0.74 RXRA (0.43) CYP3A4ADRA2CHTR2ASLC6A4ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8202876-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-06-19 — — US disclosed
US-8202876-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-06-19 — — US disclosed
US-8202876-B2 Compounds and compositions as protein kinase inhibitors IRM LLC (BM) 2012-06-19 — — US disclosed
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-04 — — US disclosed
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-04 — — US disclosed
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2010-02-04 — — US disclosed
EP-2057146-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2009-05-13 — — EP disclosed
WO-2008042639-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-04-10 — — WO disclosed
WO-2008042639-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS IRM LLC (BM) 2008-04-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029605-A1 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS FYN, ABL2, LCK NOTUM 3800/4885NPSR1 2526/4885ATF1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback